IBM has sought to expand its healthcare data analytics and cloud computing technology portfolio with the purchases of Explorys and Phytel for undisclosed amounts.
Cleveland-based Explorys offers cloud platforms for healthcare providers to manage clinically integrated networks, risk in patient populations, cost of care and pay-for-performance initiatives, IBM said Monday.
Explorys has built a database of approximately 315 billion operational and clinical data points.
Mike Rhodin, senior vice president at IBM’s Watson group, said the company intends for the acquisition to help accelerate adoption of Watson-powered health cloud technology for large-scale medical data analytics.
IBM also seeks to combine Phytel’s population health management software with IBM’s cognitive computing technology.
Rhodin added he believes that acquisition would support IBM’s efforts to help providers gain insight about a patient’s health with data technology.
Phytel’s cloud-based software is designed to work with electronic health records systems and help organizations manage patient engagement as well as comply with healthcare rules.
Explorys and Phytel will operate under IBM’s newly launched Watson health unit.